Licensing
AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan
AstraZeneca
PR-M05-20-NI-019May 14, 2020
FDA Approval
Allergan Receives FDA Approval for Migraine Treatment
Allergan, plc
PR-M01-20-NI-001Jan 02, 2020
Collaboration
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
Allergan, plc
PR-M11-19-NI-013-1960Nov 14, 2019
M&A
AbbVie Issues Large Bond to Finance Allergan Merger
Nice Insight
PAO-M11-19-NI-006Nov 12, 2019
Recall
FDA Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from Market
U.S. Food & Drug Administration
PR-M07-19-NI-071Jul 26, 2019
M&A
AbbVie to Acquire Allergan for $63 Billion
AbbVie
PR-M06-19-NI-052Jun 25, 2019
FDA Approval
Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients
Allergan, plc
PR-M03-19-NI-054Mar 20, 2019
Data
Allergan Presents Data From Seven Abstracts At The 2019 American Academy of Dermatology (AAD) in Washington D.C.
Allergan, plc
PR-M03-19-NI-004Mar 01, 2019
Biosimilar
Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab
Amgen
PR-M01-19-NI-079Jan 28, 2019
R&D
Allergan Establishes R&D Group in Massachusetts
Nice Insight
PAO-M01-19-NI-010Jan 09, 2019
FDA Approval
Allergan Bags Another Body Contouring Approval
Nice Insight
PAO-M10-18-NI-023Oct 22, 2018
Clinical Study
Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease
Allergan, plc
PR-M10-18-NI-024Oct 08, 2018
Acquisition
Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-015Sep 19, 2018
Appointment
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Allergan, plc
PR-M08-18-NI-096Aug 22, 2018
Fast Track
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Allergan, plc
PR-M07-18-NI-080Jul 24, 2018
Announcement
Science Exchange Adds Allergan EVP & Chief R&D Officer David Nicholson to Its Board of Directors
Science Exchange
PR-M06-18-NI-099Jun 29, 2018
Clinical Data
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant
Allergan, plc
PR-M06-18-NI-051Jun 14, 2018
Drug Delivery
Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting
Allergan, plc
PR-M04-18-NI-55Apr 17, 2018
Results
Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression
Allergan, plc
PR-M04-18-NI-018Apr 05, 2018
Earnings
Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast
Allergan, plc
PR-M04-18-NI-012Apr 04, 2018